Sartorius Stedim Biotech (SSB) has entered into a global development agreement with em-tec, a company that specializes in non-invasive flow engineering solutions for biopharma processes for accurate measurement of flow rates and mass balances. In particular, this technology is used in downstream processes, such as virus inactivation, as well as in ultrafiltration and diafiltration.   Em-tec will employ its technology to jointly develop single-use components, such as FlowTube. Sartorius will excl...